These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 4977481)
21. Attenuated Liu Q; Li P; Luo H; Curtiss R; Kong Q Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075 [No Abstract] [Full Text] [Related]
22. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564 [TBL] [Abstract][Full Text] [Related]
23. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines. Zuckerman JN; Hatz C; Kantele A Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924 [TBL] [Abstract][Full Text] [Related]
28. [Typhoid and paratyphoid fever]. Trawinski H; Wendt S; Lippmann N; Heinitz S; von Braun A; Lübbert C Z Gastroenterol; 2020 Feb; 58(2):160-170. PubMed ID: 32050286 [TBL] [Abstract][Full Text] [Related]
29. Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A. Yin J; Cheng Z; Wu Y; He Q; Zhang J; Yang Z; Ding S; Li J; Guo D Microb Pathog; 2019 Dec; 137():103795. PubMed ID: 31610219 [TBL] [Abstract][Full Text] [Related]
30. The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies. Gibani MM; Voysey M; Jin C; Jones C; Thomaides-Brears H; Jones E; Baker P; Morgan M; Simmons A; Gordon MA; Cerundolo V; Pitzer VE; Angus B; Levine MM; Darton TC; Pollard AJ Clin Infect Dis; 2019 Apr; 68(8):1265-1273. PubMed ID: 30252031 [TBL] [Abstract][Full Text] [Related]
31. [New laboratory test for the study of post-vaccination immunity and evaluation of the protective capacity of intestinal typhus vaccines]. Levina LA; Kheĭfets LB; Zaĭdner IG; Stanislavskiĭ ES Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):40-3. PubMed ID: 816122 [TBL] [Abstract][Full Text] [Related]
32. [Immunochemical study of the antigenic complexes from typhoid-paratyphoid A and B bacteria obtained industrially]. Khatuntseva NV; Mironova MV; Riapolova RG; Rybasova GV Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):50-5. PubMed ID: 4409774 [No Abstract] [Full Text] [Related]
33. [Chick-embryo sero-protection test for evaluation of efficacy of the oral immunization by inactivated T.A.B. vaccine]. Dimache G Ann Sclavo; 1972; 14(5):599-610. PubMed ID: 4669414 [No Abstract] [Full Text] [Related]
34. Modern practice in immunization. 3. Typhoid and paratyphoid immunization. BANKER DD Indian J Med Sci; 1957 Jul; 11(7):516 passim. PubMed ID: 13462583 [No Abstract] [Full Text] [Related]
35. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines. Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913 [TBL] [Abstract][Full Text] [Related]
36. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. Whitaker JA; Franco-Paredes C; del Rio C; Edupuganti S J Travel Med; 2009; 16(1):46-52. PubMed ID: 19192128 [No Abstract] [Full Text] [Related]
37. [Development of new types of chemical vaccine for prevention of intestinal infections and problems of their qualitative evaluation. III. Comparative study of immunologic characteristics of experimental antigenic preparations]. Karpukhin GI; Andrievskaia RA; Luk'ianova EG Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):39-43. PubMed ID: 239506 [TBL] [Abstract][Full Text] [Related]
38. [Complex experimental study on anti-Salmonella typhi vaccination. Protective property of human and rabbit serums for the mouse and chick embryo]. Dimache G; Vladoianu IR; Dimache V; Popesco P Ann Inst Pasteur (Paris); 1971 Jun; 120(6):817-29. PubMed ID: 5557381 [No Abstract] [Full Text] [Related]
39. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110 [TBL] [Abstract][Full Text] [Related]